The C3H/HeJ (C3H) and CBA/J (CBA) mouse strains are classical mouse models of cancer susceptibility, exhibiting high risks for both spontaneous and chemically induced liver cancer. By analysis of backcrosses and intercrosses between C3H or CBA and resistant B6 mice, we have mapped a potent modifier of hepatocellular carcinoma development to distal chromosome 1, linked to the marker D1Mit33 with combined LOD W scores of ‫9.5ف‬ (C3H) and 6.5 (CBA). We previously identified this region as one of two that modify susceptibility in the more distantly related C57BR/cdJ (BR) strain. Congenic B6.C3H(D1Mit5-D1Mit17) and B6.BR(D1Mit5-D1Mit17) mice developed significantly more liver tumors than B6 mice did (6-to 13-fold, P Ͻ 10 Ϫ11 , in males; 3-to 4-fold, P Ͻ 10 Ϫ3 , in females). Thus, distal chromosome 1 carries one or more genes that are sufficient to confer susceptibility to liver cancer. by the results of partial hepatectomy of DEN-treated By 2 years of age, 30-50% of C3H mice spontaneously livers. The growth stimulus provided by partial removal develop hepatocellular carcinoma (HCC), the most of the liver causes a dramatic increase in lesion number common form of liver cancer in mice and humans and size in B6, but not C3H, mice (Hanigan et al. 1990 ), (Storer 1966; Smith and Walford 1978) . In contrast, suggesting that partial hepatectomy activates in B6 a Ͻ5% of 2-year-old B6 mice develop HCC (Frith and growth pathway that is already active in C3H lesions. Wiley 1982). On the basis of modeling studies, we have This strain-specific difference in growth control is also suggested that the majority ‫)%58ف(‬ of the difference evident in untreated livers that have undergone partial in susceptibility between B6 and C3H is controlled by hepatectomy. The level of DNA synthesis in these normal hepatocytes is over twofold higher in C3H mice than in B6 mice (Bennett et al. 1995) ,
T HE C3H/HeJ (C3H) and CBA/J (CBA) mouse one locus (Drinkwater and Ginsler 1986) . This quanstrains are classical models of liver carcinogenesis, titative trait locus (QTL) has been named Hcs7 (Hepatohighly susceptible to both spontaneous and carcinogencarcinogen sensitivity 7) on the basis of a preliminary induced liver cancer (Andervont 1950; Flaks 1968;  report of its location (Bennett et al. 1993) . Smith et al. 1973) . The genetic basis for their susceptibilHcs7 appears to control early stages of tumor developity has not been established. Identifying the number ment. Preneoplastic lesions, induced by treatment of and types of genes underlying their susceptibility is likely male mice with N, N-diethylnitrosamine (DEN) or N-ethylto have public health implications, as liver cancer in N-nitrosourea (ENU) at 12-15 days of age, grow about C3H-derived B6C3F 1 mice is the single most common twofold faster in 12-to 32-week-old C3H mice than in carcinogenic response to the Ͼ500 compounds that B6 mice (Hanigan et al. 1988;  Pugh and Goldfarb have been tested in chronic bioassays by the National 1992). The implication that the net growth of preneoToxicology Program (Ashby and Tennant 1991; http:/ / plastic lesions in intact B6 livers is limited is supported ntp-server.niehs.nih.gov/; January 2004).
by the results of partial hepatectomy of DEN-treated By 2 years of age, 30-50% of C3H mice spontaneously livers. The growth stimulus provided by partial removal develop hepatocellular carcinoma (HCC), the most of the liver causes a dramatic increase in lesion number common form of liver cancer in mice and humans and size in B6, but not C3H, mice (Hanigan et al. 1990 ), (Storer 1966; Smith and Walford 1978) . In contrast, suggesting that partial hepatectomy activates in B6 a Ͻ5% of 2-year-old B6 mice develop HCC (Frith and growth pathway that is already active in C3H lesions.
Wiley 1982). On the basis of modeling studies, we have
This strain-specific difference in growth control is also suggested that the majority ‫)%58ف(‬ of the difference evident in untreated livers that have undergone partial in susceptibility between B6 and C3H is controlled by hepatectomy. The level of DNA synthesis in these normal hepatocytes is over twofold higher in C3H mice than in B6 mice (Bennett et al. 1995) , indicating that (Hanigan et al. 1988) . tumors develop mainly from C3H hepatocytes-even
After two more rounds of mating, N 4 congenic male mice from each line were crossed to B6 females to generate experimental in livers derived predominantly from B6 hepatocytes progeny (Table 1) . N 4 congenic mice were also used in contin- (Condamine et al. 1971; Lee et al. 1991) . In addition, ued backcrossing to yield animals (N 10 ) that were then inter- These congenic mice confirm the location, potency,
(1 l spleen DNA) or 21.5 (2 l DNA). The reactions were and independent action of the C3H chromosome 1 incubated in thermocyclers at 94Њ for 3 min; followed by 40 cycles of 94Њ for 30 sec, 55Њ for 40 sec, and 72Њ for 60 sec; and modifier.
followed by 7 min at 72Њ. The products were separated by LOD (logarithm of odds) scores (Kruglyak and Lander 1995) , LOD W , were estimated from LOD W ϭ 0.5 (log 10 e ) electrophoresis through a 7% acrylamide gel. B6C3F 1 ϫ B6 backcross progeny were genotyped at the (Z W ) 2 . These analyses were performed using Qlink 3.2 software, which is available from the authors (http:/ /mcardle.oncolofollowing 107 markers: D1Mit1, D2Mit1, D3Mit3,  gy.wisc.edu/qlink). D4Mit12, D5Mit11, D5Nds2 ; D6Mit1, D7Mit7, D7Nds1, D8Mit4, D9Mit2, D9Nds2; D10Mit3, D10Nds1; D11Mit2, D12Mit5, ; D12Nds2, B6C3F 1 ϫ B6 backcross and B6C3F 2 intercross: The D13Mit3, D14Mit5, D15Mit6,  high sensitivity of C3H mice is governed largely by a D15Nds2; D16Mit4, D17Mit1,  single locus (Drinkwater and Ginsler 1986) . To map D18Mit4, and D19Mit1, this QTL, we generated 58 B6C3F 1 ϫ B6 backcross male of 34 animals, randomly chosen, was tested at every marker locus. The remaining 24 progeny were tested only at marker progeny, injected them with DEN at 12 days of age, and loci on chromosomes showing significant linkage to the tumor counted their liver tumors at 32 weeks of age. The tumor multiplicity phenotype. B6C3F 2 mice were typed at the followmultiplicity phenotypes were correlated with genotypes ing 50 markers: D1Mit3,  at 107 microsatellite markers spread at ‫-51ف‬cM intervals D2Mit7, D3Mit7, D4Mit12 ; D5Nds2; D5Mit24; D6Mit33, D7Nds1; D8Mit4,  throughout the 19 autosomes. (Previous analysis of F D9Mit4; D10Mit68; D11Mit14, D12Mit5,  mice had shown that the locus was not carried by the D13Mit3, -13, -35, -51; D14Mit14, -28; D15Mit2, -6 ; D16Mit4 ; X or Y chromosomes; Drinkwater and Ginsler 1986.) D17Mit3, and D18Mit17, Segregation analysis reveals a significantly linked region Fifty-three B6CBF 1 ϫ B6 backcross progeny were genotyped centered at D1Mit15 at 88 cM on chromosome 1, with at the following 74 marker loci: D1Mit3, D2Mit1, D3Mit62,  a LOD W of 3.06 (genome-wide P value ϭ 0.0067; Figure   - 6, D4Mit9, D5Mit61, D5Nds2;  1A). B6C3F 1 ϫ B6 mice heterozygous for the C3H allele respectively. D1Mit3, 113, D12Mit5, and We independently tested this region's ability to mod- bolic activation, ENU is a direct-acting alkylating agent.
Two or three animals from the B6.C3H-Ch1 and B6.BRHowever, the two carcinogens yield identical patterns Ch1 homozygous congenic lines at generation N 10 were tested of ethylated bases in DNA (Beranek et al. 1980 ) and at marker loci spaced approximately every 5 cM throughout highly similar strain distribution patterns for liver tumor the congenic region. The markers used for B6.C3H-Ch1 were D1Mit64,  induction among BXH recombinant inbred strains  and Drinkwater 1995a). Intercross mice were injected -17; markers used for B6. BR-Ch1 were D1Mit5,  intraperitoneally at 12 days and killed at 32 weeks of age. Again, C3H alleles on distal chromosome 1 were indicates markers that were used to identify breeders during most tightly linked with liver tumor susceptibility (Figbackcrossing to generate the congenic lines.
Linkage analysis: We used a nonparametric approach to ure 1A). Specifically, D1Mit13 at 63 cM yielded a signifiassess linkage between the marker loci and the quantitative cant LOD W score of 2.85 (P genome ϭ 0.007; Figure 1A ). interaction of recessive B6 alleles on chromosome 1 (Doerge and Churchill 1996) . This analysis should also reveal interactions between major and minor loci. Equivalent with recessive C3H alleles elsewhere might not have been detected. Interactions with dominant C3H alleles Congenic backcross: The above mapping crosses between B6 and C3H or CBA and previous mapping elsewhere should have been detected in the backcross. B6CBF 1 ϫ B6 backcross and B6CBF 2 intercross: The crosses between B6 and BR (Poole and Drinkwater 1996) identified modifiers of liver cancer risk on distal CBA inbred strain was derived from the same C line as C3H and is almost identically susceptible to liver cancer, chromosome 1. To verify the existence of these modifiers and test their ability to act alone, we generated whether spontaneous or induced by a variety of carcinogens (Grasso and Hardy 1975; Drinkwater 1989) . congenic animals carrying C3H or BR chromosome 1 regions on a B6 background. We selected for C3H or To map the CBA susceptibility loci, 53 B6CBF 1 ϫ B6 backcross and 95 B6CBF 2 intercross male progeny were BR alleles at four marker loci spanning a 70-cM region of chromosome 1, from D1Mit5 to D1Mit17. After three injected with DEN at 12 days of age and tumors were counted at 32 weeks of age. The tumor multiplicity generations of backcrossing, mice from four to five independent congenic lines (then at N 4 ) were crossed to B6 phenotypes of 53 backcross animals were correlated with their genotypes at 74 marker loci at ‫-02ف‬cM intervals.
to generate N 5 backcross progeny. (On average, unlinked C3H or BR alleles outside the congenic region Marker D1Mit113 at 93 cM on chromosome 1 yielded a significant LOD W score of 3.29 (P genome ϭ 0.0036; Figure  should compose only ‫%3ف‬ of the genome in these N 5 congenics, with each subline carrying a different com-1B). The results of the F 2 intercross confirm the presence of a single strong modifier on chromosome 1. plement of residual heterozygosity.) The N 5 congenics were treated with DEN and their tumors were counted, Significant linkage spanned the region between D1Mit13 and D1Mit17, completely overlapping the susyielding additional mapping data and an initial assessment of the allele's ability to act independently. Among ceptibility region in C3H, with a peak LOD W score of 3.21 at D1Mit33 at 82 cM (P genome ϭ 0.0011; Figure 1B) . 138 mice, progeny heterozygous for C3H or BR chromosome 1 alleles developed 4-to 5-fold more tumors than Animals carrying the dominant CBA allele developed between 2.5-and 3-fold more tumors than B6 homozytheir homozygous B6 siblings did ( Many of the backcross progeny carried newly recomin parallel, developed 166 Ϯ 157 and 4 Ϯ 6 tumors, respectively. No other loci were found to interact sigbinant chromosomes in the large congenic region. These novel recombinants were used to map the modnificantly with the chromosome 1 modifier. ifier. Once again, peak linkage was near D1Mit33, with 78% of the 27-fold effect between the B6 and C3H strains (in terms of relative risk), and the 4-fold effect a LOD W of 5.08 (P Ͻ 10 Ϫ4 ) for B6.C3H-Ch1 and a LOD W of 4.52 (P Ͻ 10 Ϫ4 ) for B6.BR-Ch1. The data for all of in B6.C3H-Ch1 females accounts for 86% of the 5-fold effect between strains. Homozygosity for BR chromothe C3H and CBA mapping crosses are shown in Figure  1 . Each cross yielded a highly significant LOD W for distal some 1 resulted in a 6-fold increase in B6.BR-Ch1 males (P Ͻ 10
Ϫ8
) and a 3-fold increase in B6.BR-Ch1 females chromosome 1. Combined, the three C3H crosses yield a LOD W of 11.0, and the two CBA crosses yield a LOD W of relative to B6 (P Ͻ 10
Ϫ3
). The effect in males accounts for 100% of the 6-fold difference in susceptibility be-6.5. Combining our previous linkage results for crosses between B6 and BR mice (Poole and Drinkwater tween B6 and BR, but the 3-fold effect in females accounts for only 42% of the 14-fold difference between 1996) with those for the B6.BR-Ch1 backcross yields a peak LOD W score of 11.2 at D1Mit33.
B6 and BR females. The discrepancy in females is due to susceptibility alleles on chromosome 17 (Poole and Susceptibility of congenic mice: We continued backcrossing the congenic animals carrying C3H or BR chroDrinkwater 1996). Chromosome 1 alleles from both C3H and BR appear semidominant in females and domimosome 1 regions to B6 animals and assessed the heterozygous and homozygous effects of each congenic nant in males. Tumors induced in parental and congenic mice were region in a single 10th-generation line (N 10 ; 0.1% unlinked donor genome). At this generation, the congenic selected randomly and assessed histopathologically. The tumors were all hepatocellular in origin, with the excepregion consisted of the selected 70-cM interval and up to 40 additional megabase pairs proximal to D1Mit5. tion of one cholangioma and three sections that exhibited nodules consistent with lymphoma. Among the 211 We found that the C3H and BR chromosome 1 regions impart dramatic susceptibility to both males and hepatocellular tumors examined, approximately equal numbers were diagnosed as adenomas and carcinomas. females (Table 2) . Homozygosity for 70 cM of C3H chromosome 1 caused congenic males to develop 13-
The distribution between tumor types was independent of gender or strain. Hematoxylin-and eosin-stained liver fold more tumors than B6 males (P Ͻ 10 Ϫ11 ) and congenic females to develop 4-fold more tumors than B6 sections from B6, B6.C3H-Ch1 congenic, and C3H mice were also scored for eosinophilic inclusions. Although females (P Ͻ 10
Ϫ7
). [Similar results were obtained with B6, C3H, and B6.C3H-Ch1 animals fed a diet containing commonly found in B6 hepatic lesions (Kakizoe et al. 1989) , previous results suggested that these inclusions 6% rather than 9% fat (data not shown).] These increases account for most of the difference in susceptibildo not segregate with resistance to liver tumorigenesis (Lee and Drinkwater 1995a) . We observed many incluity between B6 and C3H, for both genders. Specifically, the 13-fold effect in B6.C3H-Ch1 males accounts for sions in susceptible B6.C3H-Ch1 livers, confirming the ity to a similar degree in both genders (Table 2) .
The congenic (N 10 ) Hcs7 C3H modifier appears domiMice were treated at 12 days of age with DEN (0.1 mol/g nant in males and semidominant in females ( water 1996). The possibility that Hcs7 and Hcf2 repreg P Ͻ 0.02. sent the same gene is supported by chimera analysis and the congenic data presented in Tables 1 and 2 . In independent segregation of the inclusion and tumor both C3H ↔ B6 chimeras and BR ↔ B6 chimeras, turesistance phenotypes (data not shown).
mors develop mainly from the cells of the susceptible parent, suggesting that the predominant modifiers in C3H and BR act within hepatocytes (Condamine et al.
DISCUSSION
1971; Lee et al. 1991; Chiaverotti and Drinkwater 2003) . In addition, both B6.C3H-Ch1 mice and B6.BRDistal chromosome 1 carries one or more potent modifiers of liver cancer risk that account for most of the Ch1 mice develop severalfold more tumors than do B6. However, the effect of the BR congenic region is less difference in tumor multiplicity between the C3H and B6 strains and all of the difference between BR and B6 than that of the C3H region (6-fold vs. 13-fold). This ‫-2ف‬fold difference might be explained by the presence males. Linkage analysis of crosses between the B6 and C3H or CBA strains indicate that a QTL, Hcs7, lies near of two (or more) polymorphic modifiers, only one of which is common to BR and C3H. Complexity in polyD1Mit33 at 82 cM. Our congenic analyses show that the C3H allele of Hcs7 (Hcs7
C3H
) is sufficient to confer morphic modifier regions is frequent and might reflect the inheritance of linked gene families among inbred susceptibility to the resistant B6 strain. The identification of Hcs7 is based on both F 1 and congenic backstrains (Cormier et al. 2000; reviewed in Balmain 2002) . Linked modifiers might also help explain the greater crosses, as well as F 2 intercrosses. Its location and independence were confirmed using N 10 congenic lines.
effect of the Hcs7 region in the congenic lines than in the backcross and F 2 mice. In the congenics, the Hcs7 These methods exceed the most rigorous guidelines for QTL analysis promoted in a recently published white locus might act additively with other minor loci in the region, while in the segregating crosses the linked genes paper by the Complex Trait Consortium (2003) . No other loci that are polymorphic in these crosses interact would be separated by recombination at some frequency (results; Poole and Drinkwater 1996). The presence significantly with the Hcs7 modifier. We have been unable to map Hcs7 in several B6 ϫ C3H recombinant of a linked modifier might also explain the broad peak of the B6C3F 2 cross. Alternatively, the more proximal inbred strains (Lee and Drinkwater 1995a) , an observation that bears further study and might reveal interacdistribution of this intercross peak might reflect loci that depend on the carcinogen used to induce the tutions between recessive B6 and C3H alleles. Hcs7 C3H has a 13-to 14-fold effect on liver tumor multimors. We are resolving this issue by fine-structure mapping. plicity in congenic males. The only known modifiers more potent than Hcs7 in the liver are gender and Much of the Hcs7 region of chromosome 1 is ortholo-
